Online citations, reference lists, and bibliographies.
← Back to Search

Nanoparticles In Medicine: Therapeutic Applications And Developments

L. Zhang, F. Gu, J. M. Chan, A. Wang, R. Langer, O. Farokhzad
Published 2008 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
Nanotechnology is the understanding and control of matter generally in the 1–100 nm dimension range. The application of nanotechnology to medicine, known as nanomedicine, concerns the use of precisely engineered materials at this length scale to develop novel therapeutic and diagnostic modalities. 1 , 2 Nanomaterials have unique physicochemical properties, such as ultra small size, large surface area to mass ratio, and high reactivity, which are different from bulk materials of the same composition. These properties can be used to overcome some of the limitations found in traditional therapeutic and diagnostic agents.
This paper references
10.1021/JA0343095
Ceramic-based nanoparticles entrapping water-insoluble photosensitizing anticancer drugs: a novel drug-carrier system for photodynamic therapy.
I. Roy (2003)
10.1016/J.ADDR.2004.02.014
Nanoparticle and targeted systems for cancer therapy.
L. Brannon-Peppas (2004)
10.1007/s11095-006-9132-0
Micellar Nanocarriers: Pharmaceutical Perspectives
V. Torchilin (2006)
Internalizing antibodies are necessary for improved therapeutic efficacy of antibody-targeted liposomal drugs.
P. Sapra (2002)
How to stabilize phospholipid liposome (using nanoparticles)
L. Zhang (2006)
10.1161/CIRCULATIONAHA.106.619056
Inflammation in Atherosclerosis: Visualizing Matrix Metalloproteinase Action in Macrophages In Vivo
J. Deguchi (2006)
10.1007/s11095-006-9203-2
Surfactant-polymer Nanoparticles: A Novel Platform for Sustained and Enhanced Cellular Delivery of Water-soluble Molecules
M. Chavanpatil (2006)
10.1080/10611860701231810
Targeted nanoparticle-based drug delivery and diagnosis
D. Emerich (2007)
10.1016/J.NANO.2005.03.002
Nanotechnology, nanomedicine, and the development of new, effective therapies for cancer.
E. Kawasaki (2005)
10.1021/BM0501454
Polymersome encapsulated hemoglobin: a novel type of oxygen carrier.
D. R. Arifin (2005)
10.1073/pnas.2232479100
Nanoshell-mediated near-infrared thermal therapy of tumors under magnetic resonance guidance
L. R. Hirsch (2003)
10.1007/s11095-005-9396-9
PEGylated Peptide Dendrimeric Carriers for the Delivery of Antimalarial Drug Chloroquine Phosphate
D. Bhadra (2005)
10.1021/MP050023Q
Dendrimers as drugs: discovery and preclinical and clinical development of dendrimer-based microbicides for HIV and STI prevention.
T. D. Mccarthy (2005)
10.1007/s100190100124
Nanotechnology
J. Gilman (2001)
10.1080/10611860600965914
Poly (propyleneimine) dendrimer based nanocontainers for targeting of efavirenz to human monocytes/macrophages in vitro
T. Dutta (2007)
10.1200/JCO.2005.08.002
Nanoparticle albumin-bound paclitaxel for metastatic breast cancer.
M. Harries (2005)
10.1016/S0163-7827(03)00033-X
Stealth liposomes and long circulating nanoparticles: critical issues in pharmacokinetics, opsonization and protein-binding properties.
S. Moghimi (2003)
10.1038/SJ.MT.6300029
Dendritic cell function after gene transfer with adenovirus-calcium phosphate co-precipitates.
M. P. Seiler (2007)
10.1021/NL0500555
Covalently linked Au nanoparticles to a viral vector: potential for combined photothermal and gene cancer therapy.
M. Everts (2006)
10.2174/138945006777435245
Nanoparticle-based diagnosis and therapy.
D. Groneberg (2006)
10.1016/J.EJPB.2006.10.022
In vivo evaluation of a new polymer-lipid hybrid nanoparticle (PLN) formulation of doxorubicin in a murine solid tumor model.
H. L. Wong (2007)
10.1073/PNAS.0601755103
Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo.
O. Farokhzad (2006)
10.1016/S0169-409X(02)00021-2
The origin of pegnology.
F. F. Davis (2002)
10.1021/JA060367P
A new class of silica cross-linked micellar core-shell nanoparticles.
Q. Huo (2006)
10.1002/ijc.22709
Nanomedicine for drug delivery and imaging: A promising avenue for cancer therapy and diagnosis using targeted functional nanoparticles
Y. Liu (2007)
10.1158/0008-5472.CAN-06-2066
Dendrimer-encapsulated camptothecins: increased solubility, cellular uptake, and cellular retention affords enhanced anticancer activity in vitro.
Meredith T. Morgan (2006)
10.1023/A:1022608321861
Liposome-Mediated Targeting of Enzymes to Cancer Cells for Site-Specific Activation of Prodrugs: Comparison with the Corresponding Antibody-Enzyme Conjugate
M. J. Fonseca (2004)
10.1038/nbt1006-1211
The emerging nanomedicine landscape
Volker Wagner (2006)
10.1016/J.ADDR.2003.10.038
On the formulation of pH-sensitive liposomes with long circulation times.
S. Simões (2004)
10.1016/S0168-3659(02)00009-3
Pluronic block copolymers as novel polymer therapeutics for drug and gene delivery.
A. Kabanov (2002)
10.1166/JNN.2006.440
Improved oral delivery of paclitaxel following administration in nanoemulsion formulations.
S. Tiwari (2006)
results of a randomized phase III clinical trial
Northfelt (1998)
10.1016/S0169-409X(97)00136-1
Controlling liposome blood clearance by surface-grafted polymers.
Woodle (1998)
10.1002/cmdc.200700121
Co‐Delivery of Hydrophobic and Hydrophilic Drugs from Nanoparticle–Aptamer Bioconjugates
L. Zhang (2007)
Hybrid virus–polymer materials
Raja (2003)
10.1080/10611860500206674
Targeting of daunomycin using biotinylated immunoliposomes: Pharmacokinetics, tissue distribution and in vitro pharmacological effects
A. Schnyder (2005)
in vivo biodistribution and anti-tumor activity
Hyung Park (2006)
10.1021/bm025740
Hybrid virus-polymer materials. 1. Synthesis and properties of PEG-decorated cowpea mosaic virus.
K. Raja (2003)
10.1158/1078-0432.CCR-05-0720
Phase I and Pharmacologic Study of PKI166, an Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor, in Patients with Advanced Solid Malignancies
R. Hoekstra (2005)
10.1016/J.IJPHARM.2003.09.050
Tumor targeting based on the effect of enhanced permeability and retention (EPR) and the mechanism of receptor-mediated endocytosis (RME).
T. Tanaka (2004)
10.1038/nrc1958
Polymer conjugates as anticancer nanomedicines
R. Duncan (2006)
10.1038/nrd1632
Recent advances with liposomes as pharmaceutical carriers
V. Torchilin (2005)
10.1021/NL052455Y
How to stabilize phospholipid liposomes (using nanoparticles).
L. Zhang (2006)
10.1016/j.bbr.2006.06.001
Improvement of cationic albumin conjugated pegylated nanoparticles holding NC-1900, a vasopressin fragment analog, in memory deficits induced by scopolamine in mice
Y. Xie (2006)
10.1016/J.ADDR.2006.09.011
Nanomedicine: developing smarter therapeutic and diagnostic modalities.
O. Farokhzad (2006)
10.1200/JCO.1998.16.7.2445
Pegylated-liposomal doxorubicin versus doxorubicin, bleomycin, and vincristine in the treatment of AIDS-related Kaposi's sarcoma: results of a randomized phase III clinical trial.
D. Northfelt (1998)
10.1158/1078-0432.CCR-05-2318
In vitro and In vivo Antitumor Activity of the Novel Derivatized Polyvinyl Alcohol-Based Polymer P10(4)
L. Raffaghello (2006)
10.1088/0953-8984/18/38/S24
Drug loaded magnetic nanoparticles for cancer therapy
R. Jurgons (2006)
10.1158/0008-5472.CAN-04-3921
Nanoparticle targeting of anticancer drug improves therapeutic response in animal model of human epithelial cancer.
J. Kukowska-Latallo (2005)
10.1007/s11060-005-9059-z
The effect of thermotherapy using magnetic nanoparticles on rat malignant glioma
A. Jordan (2005)
In vitro and in vivo antitumor activity of methotrexate conjugated to human serum albumin in human cancer cells.
K. Wosikowski (2003)
10.1021/BM050144B
Engineering temperature-sensitive hydrogel nanoparticles entrapping hemoglobin as a novel type of oxygen carrier.
J. N. Patton (2005)
10.1016/J.BIOMATERIALS.2005.05.028
Self-assembled nanoparticles based on glycol chitosan bearing hydrophobic moieties as carriers for doxorubicin: in vivo biodistribution and anti-tumor activity.
Jae Hyung Park (2006)
10.1038/sj.bjc.6601922
Phase I and pharmacokinetic (PK) study of MAG-CPT (PNU 166148): a polymeric derivative of camptothecin (CPT)
D. Bissett (2004)
pharmaceutical perspectives
Torchilin (2007)
10.1038/CLPT.1992.49
Notes of the American Society for Clinical Pharmacology and Therapeutics
D. Abernethy (1991)



This paper is referenced by
Self-Assembled LipidPolymer Hybrid Nanoparticles: A Robust Drug Delivery
P. Zhang (2008)
10.1038/nrd2591
Strategies in the design of nanoparticles for therapeutic applications
Robby A. Petros (2010)
10.1002/anie.201001868
Poly(ethylene glycol) with observable shedding.
W. Gao (2010)
The effects of magnesium nanovesicle formulations on spatial memory performance in mice.
M. Boancă (2014)
ACUTE TOXICITY EFFECTS OF TiO2 AND Cd(OH)2 NANOPARTICALS (NPS) ON EARTHWORM SPECIES, Eudriles eugeniae
S. S. Patole (2015)
10.2147/IJN.S85915
Fiber-optic triggered release of liposome in vivo: implication of personalized chemotherapy
H. Huang (2015)
10.1038/nature08602
Designing materials to direct stem-cell fate
M. Lutolf (2009)
10.1517/14712598.2012.661710
Nanoparticles disguised as red blood cells to evade the immune system
R. Fang (2012)
10.4155/tde.12.127
Intelligent design of multifunctional lipid-coated nanoparticle platforms for cancer therapy.
Srinivas Ramishetti (2012)
10.1021/jf4023004
Nanoencapsulation enhances epigallocatechin-3-gallate stability and its antiatherogenic bioactivities in macrophages.
J. Zhang (2013)
10.7763/IJBBB.2013.V3.276
Prevention of Contrast Medium Induced Nephropathy by Liposome Encapsulation
Gi-Da Lee (2013)
Effect of Green Synthesized Silver Nanoparticles Incorporated with Gelatin for Sustained Drug Release
P. Kalainila (2014)
Formulation and evaluation of novel vancomycin loaded lipidpolymer hybrid nanoparticles for effective antibiotic therapy.
Nasreen. Seedat (2015)
Polymeric immunonanoparticles for active tumor targeting: preparation, characterization and "in vivo" evaluation
Adriana Cirstoiu (2009)
10.1021/acsami.5b07631
Protein Adsorption From Biofluids on Silica Nanoparticles: Corona Analysis as a Function of Particle Diameter and Porosity.
Alden M. Clemments (2015)
10.1021/nn301159a
Softer zwitterionic nanogels for longer circulation and lower splenic accumulation.
Lei Zhang (2012)
10.1016/j.ejbas.2017.10.008
Polyphenon-E encapsulated into chitosan nanoparticles inhibited proliferation and growth of Ehrlich solid tumor in mice
A. I. Othman (2018)
10.1016/j.mimet.2019.105766
New avenues of controlling microbial infections through anti-microbial and anti-biofilm potentials of green mono-and multi-metallic nanoparticles: A review.
Palashpriya Das (2019)
10.1007/s11060-020-03559-9
Nanoparticles as immunomodulators and translational agents in brain tumors
Adam J Grippin (2020)
10.1039/c5cc03232f
Controlled release from protein particles encapsulated by molecular layer deposition.
S. A. Vasudevan (2015)
10.1038/aps.2017.16
Self-assembled nanocomplex between polymerized phenylboronic acid and doxorubicin for efficient tumor-targeted chemotherapy
Junseok Lee (2017)
10.1002/jps.24307
Determination of key parameters for a mechanism-based model to predict Doxorubicin release from actively loaded liposomes.
Eva Csuhai (2015)
10.1088/2043-6262/6/1/015008
Nanoparticles: synthesis and applications in life science and environmental technology
Hoàng Lương Nguyễn (2014)
10.1515/med-2017-0041
Therapeutic nanomedicine surmounts the limitations of pharmacotherapy
Arome Solomon Odiba (2017)
10.1007/s13346-018-0496-6
Polysialic acid-polyethylene glycol conjugate-modified liposomes as a targeted drug delivery system for epirubicin to enhance anticancer efficiency
T. Zhang (2018)
10.1002/9781118462157.CH12
Liposome as efficient system for intracellular delivery of bioactive molecules
Mihaela Trif (2015)
10.1177/2049936117713593
The role of nanotechnology in the treatment of viral infections
Lavanya Singh (2017)
10.1080/07388551.2016.1199010
Bactericidal, quorum quenching and anti-biofilm nanofactories: a new niche for nanotechnologists
B. Singh (2017)
10.1016/J.PQUANTELEC.2018.12.001
Design and realization of light absorbers using plasmonic nanoparticles
L. Escoubas (2019)
10.1002/smll.201301111
Nanoparticle-programmed self-destructive neural stem cells for glioblastoma targeting and therapy.
Y. Cheng (2013)
10.1111/j.1476-5381.2011.01768.x
Cholesteryl butyrate solid lipid nanoparticles inhibit the adhesion and migration of colon cancer cells
R. Minelli (2012)
Comparison of Anti-tumor Properties of the Cell walls of Saccharomyces Cerevisiae and Saccharomyces Boulardi Probiotics, individually and in Combination with Iron Nanoparticles on K562 Cancer cell line
Salar Mokriani (2014)
See more
Semantic Scholar Logo Some data provided by SemanticScholar